Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. - Wikidata - awgldk - TriplyDB

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

http://www.wikidata.org/entity/Q30425925

about

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic Universal immunity to influenza must outwit immune evasion Influenza virus hemagglutinin stalk-based antibodies and vaccines Animal models for influenza virus pathogenesis, transmission, and immunology Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.Novel universal influenza virus vaccine approaches Stalking influenza by vaccination with pre-fusion headless HA mini-stem Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.Workshop report: Immunoassay standardisation for "universal" influenza vaccines.Fc functional antibodies in humans with severe H7N9 and seasonal influenza Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in childre The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice Influenza-Specific Antibody-Dependent Phagocytosis.

P2860

Q24568302-68148E5E-C038-4827-8220-D143718430E7 Q26744622-651EB53D-8944-4D29-B8B7-8C8955572B17 Q26782795-B43BE343-56ED-41D2-B88F-06233757A59F Q26991896-2CD812B9-1819-4A96-868B-C2F1C94E4D1C Q27001190-9D93A2A6-D46B-4EF3-A637-ACD5CC1EFBAF Q27024582-2F108C22-F98D-44C0-8418-6AACA4E23064 Q30151352-879F1F23-27CE-4045-A316-7434A9280712 Q30207890-820AA222-B5D4-4696-A09A-AF3807A6F35F Q30354732-E344E162-5F2C-4480-BF11-4574A27886C8 Q30355516-18EA2A03-DD8A-4106-94D4-698C78048431 Q30361079-FDB88FC9-34E7-4971-8759-441E0360AEB7 Q30363454-46E5973F-E35C-4018-8CC3-8427F2E62B8B Q30363595-024C1AC0-BD25-4F67-BB45-85845FE742F5 Q30366832-AA19D7AE-A9EB-41FB-9DB5-614665D1E3E3 Q30369956-0E509573-6EEA-419B-AD47-ED76A5FF166D Q30375348-C02B8A3F-A8DB-4AA1-91F9-0C568689972F Q30381056-B2D26C92-020F-4ADA-85A6-70D80E445901 Q30382351-94F42E6A-5A10-42A4-B5E7-2A8C26353059 Q30382787-8F078DCA-8C76-4277-8780-40471528E456 Q30385071-610B2F5B-17F1-43E9-A439-2A60D787F884 Q30385331-BA6CEDAD-1F5C-4D8B-B852-EA832CB4A599 Q30389916-FCD9D75F-20A3-4D5D-9879-3DA5FB762685 Q30390233-435084CC-FC92-4B90-B699-BD1F57C94CCC Q30391515-21B3936E-5431-4D71-9AF5-C9740DD27D12 Q30400230-AAFB0CEC-56B5-406B-BCDF-597037184C19 Q30400732-0D2C6195-81DD-4784-BB78-C2CEF1CA79E2 Q30401056-C46EEC8F-448D-44C0-9E75-5896E9FBD17F Q30427950-571FB73A-9C35-41F2-B0B2-A44C83877219 Q30432591-993A05D7-098A-434C-A9E8-CDC88F24A3D4 Q33619871-12522C5A-35A7-42CD-9D3A-A3F510B0DE0D Q33877811-7BB13D76-5CF7-4AE7-A061-CEB5A0843BBB Q33904286-5C958B4F-3855-4D74-9706-7E8C96B07D4D Q34057737-27F1CA2D-8011-4B4C-82CD-5082EF8E3643 Q34283944-84FA4C99-C054-468C-ADD9-F5718F80283C Q35225020-60C3B110-8AEE-40F0-A768-8B02F021061C Q35542801-B8AB9545-0DDB-44CC-8B0E-F1471E093901 Q35756765-AC30FE4A-8E38-4127-B473-B775AEB70343 Q35826733-E884B00D-95A8-4AA0-979F-99932554B4ED Q35982805-8ECEF261-E649-4BEB-91FF-AB00898C52AE Q36002107-503863B6-D426-4532-A9A2-F45AD1D7AE6F

P2860

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

http://www.wikidata.org/entity/Q30425925

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@ast

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@en

type

label

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@ast

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@en

prefLabel

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@ast

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@en

P1433

Q30425925-7D0C3C91-0508-45F3-922F-F04F85980D47

P1476

Q30425925-663A484E-A1EA-438E-BBAE-1A74C737B0AE

P2093

Q30425925-24AD5E66-22F3-4F90-9BE0-ABECC894E6BC

Q30425925-4F26D40B-0367-499A-BCB7-EC623F696969

Q30425925-54EC644C-9F40-40FD-929F-07148FEEE866

Q30425925-7BDD72DA-9FA7-4FBF-BC7C-DA877F71F9FC

P304

Q30425925-793BAA5D-423A-4BC4-B8F8-9ADEA43D410B

P31

Q30425925-ED032D81-4E8F-49D1-B257-A73ADFDA791D

P356

Q30425925-2B414055-EFBE-4082-BD32-2A1703C5C4BC

P407

Q30425925-D4CA7BAB-223F-4FBA-9B71-4498EC7F5DC8

P433

Q30425925-C8B5AA4B-3234-4DBA-9677-5F15447A266C

P478

Q30425925-FD589F4D-1E12-41E7-A742-9CF1A7BB583B

P50

Q30425925-3B092457-246F-453F-A08E-ED3979C73729

Q30425925-3E5CBD6E-2206-4998-B16E-63F918A05EC7

Q30425925-4234E0EE-50C9-49F2-AC0E-3BEAC826FF4E

Q30425925-424B6E72-CE0E-479E-99DD-E8BEC29DA22A

Q30425925-7EBCC12A-5C70-4ABC-A651-30A8AFA2677E

Q30425925-9AE2DC78-4E30-4060-BA35-AA38E6AC0199

Q30425925-BF88FDC9-0255-48F4-867C-60739A367BA4

P577

Q30425925-4FE6A03B-8CC6-4AB5-8152-FC00E083A0B0

P698

Q30425925-83938B96-2FC0-4231-B4A9-0154DEC8FD00

P921

Q30425925-1A8D4B8B-34C7-4E2C-8062-9FD0BBDE532F

Q30425925-B8FFA662-EF1C-4998-9536-821BC3E2419E

P356

JIMMUNOL.1201574

P1433

Journal of Immunology

P1476

Cross-reactive influenza-speci ...... ce of neutralizing antibodies.

@en

P2093

Gamze Isitman

http://www.w3.org/2001/XMLSchema#string

Ivan Stratov

http://www.w3.org/2001/XMLSchema#string

Marit Kramski

http://www.w3.org/2001/XMLSchema#string

Wendy R Winnall

http://www.w3.org/2001/XMLSchema#string

P304

1837-1848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1201574

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P50

Sinthujan Jegaskanda

Andrew G Brooks

Stephen J. Kent

Patrick C Reading

P577

2013-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23319732

http://www.w3.org/2001/XMLSchema#string

P921